ZOETIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 158.4 USD | +3.30% |
|
+8.14% | -19.73% |
| 23/04 | Barclays Adjusts Zoetis' Price Target to $230 From $260, Keeps Overweight Rating | MT |
| 22/04 | Jefferies Lowers Zoetis Price Target to $200 from $220 | MT |
Chart calendar Zoetis Inc.
7ca6ce4b3d1e050da962e6834c.2SXTqzpPA-iOYfa1sjHRAd_7T9MSWRtkt4NA_eMl8so.jlzqxGoKZNrGMp7ggmfpV76jK5RLKCpU4OVwlLJSoJOSVeTjaQZqpvRYvw~8dfa94b1f142972cdaba99d6b9814025
Upcoming events on Zoetis Inc.
Past events on Zoetis Inc.
| 14/03/2024 06:00 pm | Barclays Global Healthcare Conference |
| 29/02/2024 10:10 pm | Bank of America Securities Animal Health Summit |
| 13/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 13/02/2024 05:30 pm | Q4 2023 Earnings Release |
| 09/01/2024 05:15 am | JPMorgan Healthcare Conference |
| 28/11/2023 11:30 pm | Piper Sandler Healthcare Conference |
| 02/11/2023 06:00 pm | Q3 2023 Earnings Call |
| 02/11/2023 04:30 pm | Q3 2023 Earnings Release |
| 12/09/2023 10:25 pm | Morgan Stanley Global Healthcare Conference |
| 08/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 08/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 01/06/2023 01:05 am | Stifel Jaws & Paws Conference |
| 25/05/2023 06:30 pm | Investor Day |
| 18/05/2023 05:30 pm | Annual General Meeting |
| 04/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 04/05/2023 04:30 pm | Q1 2023 Earnings Release |
| 06/03/2023 09:40 pm | Cowen Health Care Conference |
| 02/03/2023 11:00 pm | Bank of America Health Summit |
| 14/02/2023 07:00 pm | FY 2022 Earnings Call |
| 14/02/2023 05:30 pm | FY 2022 Earnings Release |
Past dividends on Zoetis Inc.
| 18/04/2024 | Quarterly 0.432 USD |
| 18/01/2024 | Quarterly 0.432 USD |
| 31/10/2023 | Quarterly 0.375 USD |
| 20/07/2023 | Quarterly 0.375 USD |
| 20/04/2023 | Quarterly 0.375 USD |
| 19/01/2023 | Quarterly 0.375 USD |
| 31/10/2022 | Quarterly 0.325 USD |
| 20/07/2022 | Quarterly 0.325 USD |
| 20/04/2022 | Quarterly 0.325 USD |
| 19/01/2022 | Quarterly 0.325 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6 260 6 231 0.46% | 6 675 6 602 1.1% | 7 776 7 747 0.37% | 8 080 8 043 0.46% | 8 544 8 523 0.25% | 9 166 |
|
EBITDA Million USD | Released Forecast Spread | 2 743 2 615 4.9% | 2 940 2 806 4.76% | 3 434 3 336 2.94% | 3 561 3 439 3.53% | 3 722 3 678 1.18% | 4 009 |
|
EBIT Million USD | Released Forecast Spread | 2 331 2 336 -0.23% | 2 499 2 516 -0.66% | 2 986 2 973 0.45% | 3 096 3 089 0.23% | 3 231 3 288 -1.73% | 3 539 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 801 1 822 -1.16% | 1 996 2 047 -2.5% | 2 488 2 490 -0.08% | 2 656 2 634 0.84% | 2 936 2 962 -0.87% | 3 249 |
|
Net income Million USD | Released Forecast Spread | 1 500 1 466 2.35% | 1 638 1 645 -0.42% | 2 037 2 020 0.86% | 2 114 2 123 -0.42% | 2 344 2 382 -1.61% | 2 545 |
|
EPS USD | Released Forecast Spread | 3,11 3,04 2.18% | 3,42 3,40 0.72% | 4,27 4,25 0.41% | 4,49 4,56 -1.63% | 5,07 5,19 -2.35% | 5,48 |
| Announcement Date | 13/02/20 | 16/02/21 | 15/02/22 | 14/02/23 | 13/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 967 1 932 1.81% | 1 986 1 977 0.43% | 2 052 2 026 1.3% | 2 002 2 082 -3.84% | 2 040 2 006 1.72% | 2 000 2 015 -0.76% | 2 180 2 157 1.05% | 2 151 2 174 -1.07% | 2 213 2 192 0.97% | 2 155 | 2 327 | 2 312 | 2 365 | 2 278 |
|
EBITDA Million USD | Released Forecast Spread | 756 705 7.22% | 946 794 19.12% | 887 827 7.29% | 879 859 2.29% | 849 820 3.57% | 857 | 898 | 977 | 970 | 962 | ||||
|
EBIT Million USD | Released Forecast Spread | 639 620 3.12% | 832 773 7.63% | 770 782 -1.57% | 764 786 -2.84% | 730 723 0.99% | 770 778 -1.08% | 877 820 6.94% | 839 839 -0.06% | 745 822 -9.38% | 834 | 927 | 916 | 865 | 895 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 650 | 768 | 849 | 846 | 840 | |||||||||
|
Net income Million USD | Released Forecast Spread | 414 413 0.12% | 595 529 12.37% | 529 519 1.97% | 529 523 1.13% | 461 494 -6.61% | 552 553 -0.18% | 671 583 15.18% | 596 587 1.56% | 525 559 -6.1% | 591 | 689 | 657 | 634 | |
|
EPS USD | Released Forecast Spread | 0,87 0,88 -0.76% | 1,26 1,14 11.01% | 1,12 1,13 -0.88% | 1,13 1,11 1.8% | 0,99 1,04 -4.58% | 1,19 1,18 0.63% | 1,45 1,25 16.23% | 1,29 1,26 2.18% | 1,14 1,24 -7.69% | 1,28 | 1,45 | 1,42 | 1,34 | 1,34 |
| Announcement Date | 15/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 14/02/23 | 04/05/23 | 08/08/23 | 02/11/23 | 13/02/24 | - | - | - | - | - |
| 29/04/2024 | VETOQUINOL SA: Q1 2024 Sales and Revenue Release |
| 30/04/2024 | SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 02/05/2024 11:15 am | VIMIAN GROUP AB: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | ZOETIS INC.: Q1 2024 Earnings Release |
| 08/05/2024 | ELANCO ANIMAL HEALTH INCORPORATED: Q1 2024 Earnings Release |
| 08/05/2024 | PHIBRO ANIMAL HEALTH CORPORATION: Q3 2024 Earnings Release |
| 16/07/2024 | VIRBAC: Q2 2024 Sales and Revenue Release |
| 25/07/2024 | SWEDENCARE AB: Q2 2024 Earnings Release |
Past sector events for Zoetis Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZTS Stock
- Calendar Zoetis Inc.
